Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 20 Nasopharyngeal Carcinoma 8 Lung Neoplasms 7 Colorectal Neoplasms 4 Melanoma 3 Esophageal Squamous Cell Carcinoma 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Osteosarcoma 2 Nasopharyngeal Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Esophageal Neoplasms 2 Unresectable Non-small Cell Lung Cancer 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Radiation Injuries 1 Quality of Life 1 Pleural Effusion, Malignant 1 Non-squamous Non-small Cell Lung Cancer 1 Neuroblastoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Bone Neoplasms 1 Advanced Pancreatic Cancer 1

Interventions

Radiotherapy 29 Cisplatin 12 Amifostine 11 Radiotherapy, Intensity-Modulated 7 Paclitaxel 7 Carboplatin 7 Etoposide 5 Radiosurgery 4 Donepezil 4 Brachytherapy 4 Bevacizumab 4 sargramostim 3 Surgical Procedures, Operative 3 Mental Status and Dementia Tests 3 Filgrastim 3 Diet Therapy 3 Blood Specimen Collection 3 Radiation Dose Hypofractionation 2 Radiation 2 Proton Therapy 2 Magnetic Resonance Spectroscopy 2 Low-Level Light Therapy 2 Lithium 2 Hyperbaric Oxygenation 2 Heavy Ion Radiotherapy 2 Fluorouracil 2 Fibroblast Growth Factor 7 2 Dexamethasone 2 Chemotherapy, Adjuvant 2 Androgen Antagonists 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Radiation Injuries × endostar protein × Clear all

NCT04274270 2020-03-19

SBRTLCES

Peking University Third Hospital

Phase NA Unknown

Lung Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡